 |
Pharnext
Last updated: August 28, 2024
Daniel Cohen - Co-founder, CEO
France | Funding: $356.6M (+)
Website: http://pharnext.com
Pharnext is a biopharmaceutical company engaged in the development of treatments for severe neurological diseases.
Website: http://pharnext.com
Pharnext is a biopharmaceutical company engaged in the development of treatments for severe neurological diseases.
